Thursday, May 31, 2012

Herceptin (chemical name: trastuzumab) can be an effective treatment both before and after surgery for people with HER2-positive breast cancer. It has also been shown to reduce the risk of breast cancer recurrence after initial surgery.

In this section you can learn more about:

Breastcancer.org's mission is to help women and their loved ones make sense of the complex medical and personal information about breast health and breast cancer, so they can make the best decisions for their lives. Medical information on the Breastcancer.org web site and in our printed materials is reviewed by members of our Professional Advisory Board, which includes over 60 practicing medical professionals from around the world who are leaders in their fields. We are a nonprofit organization supported by individuals, foundations, and corporations. Find more about us here.

Ask a Question

Get answers from our experts and community members.

Btn_ask_question_med
View all questions (6579) >